Inogen Inc (USD)
INGN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range34.50 | 35.71
52-Wk Range- | -
Last Close35.61
Mkt Cap (m)785.12
Dividend yield-
ISINUS45780L1044
Volume142,826.00
Exchange VenueNAS

Company Profile

Inogen Inc is a medical technology company that develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Key Information
Price/Earning56.52
Price/Book2.26
Price/Sales2.18
P/CF18.31
Rev Growth (3 year avg)21.29
EPS Growth (3 year avg)-0.01
Operating Margin % 5.47
Net Margin %5.79
Return on Equity6.40
Debt/Equity0.02

Documents

Prospectus
en 30/10/2014
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.inogen.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)112.54159.01202.83249.44358.11361.94
Operating Income (m)10.5115.0522.8627.5937.8919.79
Net Income (m)6.8311.5920.5221.0051.8520.95
Basic EPS0.330.601.021.022.440.96
Avg. Diluted Shares Outstanding (m)18.0420.7121.1021.9022.5122.24
Balance Sheet
USD201420152016201720182019
Current Assets (m)92.54114.84161.55228.49314.58292.22
Non Current Assets (m)47.5446.4752.5046.5861.32155.12
Total Assets (m)140.09161.31214.05275.07375.90447.34
Current Liabilities (m)18.7422.0122.8533.8946.5950.18
Total Liabilities (m)------
Total Equity (m)118.15134.02182.09227.04310.42344.62
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)15.7038.1631.0360.4959.9840.59
Capital Expenditure (m)-16.24-12.49-8.02-10.23-12.97-6.51
Figures are quoted in USD unless stated otherwise
-
No change
$
35.61
Last Price